Anti-CACNG4 antibody
Specifications
| Product type: | Primary antibody |
| Antigen: | CACNG4 |
| Immunogen: | Synthetic peptide within rat Cacng4 aa 150-250. |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:400-1:1000); Immunohistochemistry (1:40); Immunocytochemistry (1:40-1:100); Flow Cytometry (1:40-1:100) |
| Reactivity: | Rat and Human |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4), 1% BSA, 40% glycerol, 0.05% NaN3. |
| Concentration: | 1mg/ml |
| Purity: | Antigen affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | CACNG4 antibody |
| Calcium channel voltage dependent gamma subunit 4 antibody | |
| CCG4_HUMAN antibody | |
| Neuronal voltage gated calcium channel gamma 4 subunit antibody | |
| Neuronal voltage-gated calcium channel gamma-4 subunit antibody | |
| TARP gamma-4 antibody | |
| Transmembrane AMPAR regulatory protein gamma-4 antibody | |
| Voltage dependent calcium channel gamma 4 subunit antibody | |
| Voltage-dependent calcium channel gamma-4 subunit antibody |
Show More
Target information
Regulates the activity of L-type calcium channels that contain CACNA1C as pore-forming subunit (PubMed:21127204). Regulates the trafficking and gating properties of AMPA-selective glutamate receptors (AMPARs), including GRIA1 and GRIA4. Promotes their targeting to the cell membrane and synapses and modulates their gating properties by slowing their rates of activation, deactivation and desensitization and by mediating their resensitization (PubMed:21172611).
Provider
Erpantech Laboratory
